前列腺癌中的丸激素替代:新兴范式和治疗潜力的系统审查
Jared Robinson1, Indrajit Banerjee2, Indraneel Banerjee3
1Surgery, Joe Morolong Memorial Hospital, Vryburg, ZAF.
Cureus
|November 19, 2025
概括
替代疗法 (TRT) 不适用于治疗前列腺癌的男性. 研究表明,TRT不会恶化前列腺癌,并且可以改善治疗后的阴茎下垂男性的生活质量.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
背景情况:
- 前列腺癌是老年男性的流行癌症,受遗传,环境和种族因素的影响.
- 雄激素和前列腺敏感性与前列腺癌的发展有关.
- 传统的治疗方法包括手术,辐射和抗雄激素剥夺疗法 (ADT).
研究的目的:
- 系统地审查替代疗法 (TRT) 与前列腺癌之间的关系.
- 挑战TRT在前列腺癌患者中的常规禁忌.
- 为了澄清TRT在前列腺癌管理中的作用.
主要方法:
- 在Google学者,旅行数据库,EMBASE,PubMed和PubMed中央系统的文献审查.
- 使用的关键词:"激素替代疗法"",前列腺"",前列腺瘤"",丸激素"",泌尿学".
- 数据提取的重点是整理最新的可用信息.
主要成果:
- 在已完成前列腺癌终极治疗的男性中,外源性TRT并非禁忌.
- TRT不会改变前列腺内脱水氨 (DHEA) 水平,也不会影响前列腺环境.
- 高剂量的TRT并没有导致割抵抗性前列腺癌的疾病进展.
结论:
- TRT与前列腺癌之间没有相关性;TRT在最终治疗后并非禁忌.
- 在初级治疗后,TRT适用于阴茎缺陷男性,改善生活质量.
- 前列腺癌诊断前TRT的作用尚不清楚;知情同意至关重要. 双极性雄激素治疗 (BAT) 在晚期前列腺癌中显示出潜力.
更多相关视频
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Disorders of the Male Reproductive System
3.9K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.9K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


